Proxy Votes Now

Home › Funds › Eaton Vance › Eaton Vance Worldwide Health Sciences Fund

Eaton Vance Worldwide Health Sciences Fund (ECHSX) proxy voting record 2025-2026

Fund family: Eaton Vance · Filed by Eaton Vance Growth Trust (CIK 102816) · SEC series S000005202

Share classes and tickers: ECHSX (C000014193), EIHSX (C000081646), ERHSX (C000014194), ETHSX (C000014191)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 554 with, 16 against, 0 abstentions (not counted as with management); 9 items carried no recommendation. Shareholder proposals: 13 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Eaton Vance as a whole

The same two figures as Eaton Vance’s manager page (83,378 ballot items across 42 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEaton VanceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.7%51186.3%60,657
Backed environmental and social shareholder proposals at US companiesn/a622.5%946

Where this fund voted differently from most Eaton Vance funds

Each ballot item this fund voted is set against the votes of the other Eaton Vance funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Eaton Vance funds on 1 item (0.3% of the 328 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Eaton Vance fundsMgmtResult
Thermo Fisher Scientific Inc.2026-05-20An advisory vote to approve named executive officer compensation.ForAGAINST — 5 of 7 Eaton Vance fundsForNot approved, 31.8% support

Download all 1 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 61.6% of this fund’s 570 such votes could be given a sector; the other 219 (38.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care313154.8%
Industrials3800.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3470
Compensation591
Corporate Governance519
Capital Structure440
Audit-related430
Say-on-Pay280
Other Social Issues43
Environment or Climate33
Shareholder Rights and Defenses20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$134M102
AbbVie Inc.May 8, 2026$70M81
Johnson & JohnsonApril 23, 2026$61M151
UnitedHealth Group IncorporatedJune 1, 2026$45M121
Merck & Co., Inc.May 26, 2026$44M183
Bristol-Myers Squibb CompanyMay 5, 2026$35M151
Thermo Fisher Scientific Inc.May 20, 2026$33M130
Gilead Sciences, Inc.April 30, 2026$32M153

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalForAgainst
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 5, 2026Bristol-Myers Squibb CompanyShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 20, 2026Zoetis Inc.Shareholder proposal to permit shareholder action by written consent. Shareholder proposalForAgainst

Search this fund’s votes by company

581 ballot items at 43 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Eaton Vance Worldwide Health Sciences Fund (ECHSX) voted at 43 shareholder meetings of 40 companies, on 581 ballot items in all. Where management made a recommendation, the fund followed it on 97.2% of the items and voted against it 16 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 24 shareholder proposals. It voted FOR the board's own proposals more often than Eaton Vance's funds as a whole (95.7% against 86.3%). It voted differently from most Eaton Vance funds on 1 item.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Eaton Vance’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.